Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05210972
Status:
COMPLETED
Last Update Posted:
2022-10-26
First Post:
2022-01-12
Brief Title:
Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia
Sponsor:
Saud Al Babtain Cardiac Center
Organization:
Saud Al Babtain Cardiac Center
Study Overview
Official Title:
Severity of Newly Diagnosed Coronary Artery Disease in Patients With Newly Diagnosed Diabetes and Pre-diabetes A Cohort Study in a Cardiac Center in Saudi Arabia
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This cohort study will measure how severe is the coronary artery disease CAD at time of CAD diagnosis clinically and angiographically in the different cohorts of newly diagnosed diabetes and prediabetes versus normal glycemia patients in the study center
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None